CAMB/MAT2203 in Patients With Mucocutaneous Candidiasis (CAMB)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT02629419 |
|
Recruitment Status :
Completed
First Posted : December 14, 2015
Last Update Posted : August 18, 2022
|
Sponsor:
Matinas BioPharma Nanotechnologies, Inc.
Information provided by (Responsible Party):
Matinas BioPharma Nanotechnologies, Inc.
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Completed |
|---|---|
| Actual Primary Completion Date : | November 9, 2021 |
| Actual Study Completion Date : | August 6, 2022 |
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):